STOCK TITAN

Medical Care Technologies Inc. (OTCID:MDCE) Follows Q3 Profit Surge With Confirmed Software Development and Expanding Subsidiary Activity

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Medical Care Technologies (MDCE) reported a 270% rise in third-quarter net income while continuing paid software development and subsidiary collectibles operations. Unaudited results for the quarter ended September 30, 2026 showed net income of $192,565, versus $52,103. Revenue rose 13% to $538,981, gross profit increased 55% to $240,839, and net operating income rose 254% to $192,565. Nine-month net income reached $198,883 versus a prior-year loss of $145,347. Current liabilities were zero at quarter-end.

Development continues under its first paid external software agreement, worth up to $250,000. Subsidiary collectibles partnership activity has reached six figures, and Real Game Used maintains an authentication backlog. Subsidiaries manage approximately $20 million in private collectibles assets; potential net profits depend on completed sales. MDCE also expanded into enterprise consulting for AI model training.

Loading...
Loading translation...
12 points · 2 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

0 major · 1 point

Hollow bars mark forward-looking points. How the balance works

Positive

  • Major pointThird-quarter net income rose 270% to $192,565 from $52,103.
  • Major pointFirst paid external software agreement, valued at up to $250,000, has technical development underway. 77% of market cap
  • Moderate pointThird-quarter revenue increased 13% to $538,981 from $478,128.
  • Moderate pointThird-quarter gross profit rose 55% to $240,839 from $155,720.
  • Moderate pointInfinite Auctions and Real Game Used partnership activity has reached six figures.
7 minor points
  • Minor pointThird-quarter net operating income increased 254% to $192,565 from $54,370.
  • Minor pointNine-month net income reached $198,883, versus a prior-year net loss of $145,347.
  • Minor pointNine-month gross profit increased to $332,744 from $78,042.
  • Minor pointQuarter-end current liabilities were zero.
  • Minor pointReal Game Used maintains a continuous backlog of customer and auction-brand authentication work.
  • Minor pointSubsidiaries are managing approximately $20 million in private collectibles assets.
  • Minor pointCommercial model expanded to include enterprise consulting for AI model training.

Negative

  • Minor point. Forward-looking: it has not happened yet and may not happen.Potential net profits from managed collectibles assets are contingent on completed sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

MESA, AZ / ACCESS Newswire / November 16, 2026 / Medical Care Technologies Inc. (OTCID:MDCE) today pointed to the commercial activity supporting the profitability improvements reported in its third-quarter results.

On November 12, the Company reported unaudited results for the three and nine months ended September 30, 2026. For the third quarter, sales revenue increased 13% to $538,981 from $478,128. Gross profit rose 55% to $240,839 from $155,720. Net operating income increased 254% to $192,565 from $54,370, and net income rose 270% to $192,565 from $52,103. For the nine months ended September 30, 2026, the Company reported net income of $198,883 compared to a net loss of $145,347 in the prior-year period. Gross profit increased to $332,744 from $78,042. The Company ended the quarter with zero current liabilities.

These results align with ongoing commercial tracks. Technical development continues under the Company's first paid external software agreement, valued at up to $250,000, covering an integrated web and enterprise platform for inventory and sales workflows. Subsidiaries Infinite Auctions and Real Game Used continue operations under their partnership with a multi-billion-dollar sports card and collectibles company, with activity already reaching six figures. Real Game Used maintains a continuous backlog of customer and auction-brand authentication work. The Company has also announced that its subsidiaries are managing approximately $20 million in private collectibles assets, with potential net profits contingent on completed sales.

MDCE has expanded its commercial model to include enterprise consulting for AI model training and continues internal evaluation of MDCE Melanoma Scan Beta and its wound-monitoring application. MDCE also continues enterprise demonstrations of Strainscan Pro.

"The Q3 results show net income up 270% and gross profit up 55% while the commercial work we have already announced continues," said Marshall Perkins, CEO of Medical Care Technologies. "Software development is underway under the $250,000 agreement. The subsidiaries are generating activity through the collectibles partnership and Real Game Used's authentication backlog. The numbers reflect revenue generation across the company and its holdings."

About Medical Care Technologies Inc.
Medical Care Technologies Inc. (OTCID:MDCE) is a diversified technology company focused on the development and commercialization of artificial intelligence-powered applications spanning health, wellness, nutrition, lifestyle, and enterprise imaging analysis solutions. The Company owns subsidiaries Infinite Auctions and Real Game Used. Visit: medicalcaretechnologies.com | infiniteauctions.com | realgameused.com

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations, estimates, and projections about the Company's business and are not guarantees of future performance. Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from those expressed or implied. Such risks include the Company's ability to continue generating revenue from subsidiaries and software activities, complete development under existing agreements, and manage its capital structure. The Company undertakes no obligation to update or revise any forward-looking statements, except as required by law. Investors are cautioned not to place undue reliance on these forward-looking statements.

Contact Information:
Medical Care Technologies Inc.
1910 S. Stapley Drive, Suite 221, Mesa, AZ 85204
Phone: +1 (480) 645-0750
Email: marshall@medicalcaretechnologies.com
Website: medicalcaretechnologies.com

SOURCE: Medical Care Technologies Inc.



View the original press release on ACCESS Newswire

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What were Medical Care Technologies' third-quarter 2026 earnings?

Medical Care Technologies reported unaudited third-quarter net income of $192,565, up 270% from $52,103. For the three months ended September 30, 2026, revenue increased 13% to $538,981, and gross profit rose 55% to $240,839.

How much is MDCE's first paid external software agreement worth?

The agreement is valued at up to $250,000, with technical development continuing. It covers an integrated web and enterprise platform for inventory and sales workflows.

What is the status of MDCE's health applications and Strainscan Pro?

MDCE continues internal evaluation of MDCE Melanoma Scan Beta and its wound-monitoring application. Enterprise demonstrations of Strainscan Pro are also continuing.

Keep reading